Free Trial

Supernus Pharmaceuticals (SUPN) Insider Trading & Ownership

Supernus Pharmaceuticals logo
$49.19 +0.56 (+1.15%)
As of 05/5/2026 04:00 PM Eastern

Supernus Pharmaceuticals (NASDAQ:SUPN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$23.57M
Get SUPN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Supernus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SUPN Insider Buying and Selling by Quarter

Supernus Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/18/2026Sell7,250$49.60$359,600.00  
3/16/2026Sell50,000$50.28$2,514,000.00  
3/13/2026Sell35,000$50.37$1,762,950.00  
3/12/2026Sell5,369$50.61$271,725.09  
3/6/2026Sell8,787$53.00$465,711.00  
3/5/2026Sell10,000$53.71$537,100.00  
3/3/2026Buy$54.56$1,001 - $15,000
2/19/2026Sell4,475$51.01$228,269.75  
12/19/2025Sell20,000$50.41$1,008,200.00  
12/18/2025Sell710$44.44$31,552.40  
12/11/2025Buy$46.51$1,001 - $15,000
10/9/2025Sell59,900$50.57$3,029,143.00  
10/9/2025Sell$49.51$1,001 - $15,000
9/29/2025Sell10,235$48.02$491,484.70  
9/23/2025Sell29,513$47.23$1,393,898.99  
9/22/2025Sell16,587$47.02$779,920.74  
9/12/2025Sell5,000$45.87$229,350.00  
9/8/2025Sell6,322$46.29$292,645.38  
9/5/2025Sell55,578$46.01$2,557,143.78  
8/25/2025Sell14,000$44.51$623,140.00  
8/25/2025Sell1,000$45.00$45,000.00  
8/22/2025Sell11,780$44.49$524,092.20  
8/14/2025Sell5,369$42.25$226,840.25  
8/14/2025Sell7,457$42.26$315,132.82  
8/6/2025Sell140,000$42.02$5,882,800.00  
(Data available from 1/1/2013 forward)

SUPN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Supernus Pharmaceuticals includes Bethany Sensenig, Frank Mottola, Frederick M Hudson, Georges Gemayel, Jack A Khattar, Jonathan Rubin, Padmanabh P Bhatt, Tami Tillotson Martin, and Timothy C Dec. Learn more on insiders at SUPN.

8.80% of Supernus Pharmaceuticals stock is owned by insiders. Learn more on SUPN's insider holdings.

The following insiders have sold SUPN shares in the last 24 months: Bethany Sensenig ($455,110.00), Frank Mottola ($2,415,390.00), Frederick M Hudson ($586,857.91), Georges Gemayel ($1,523,291.06), Jack A Khattar ($20,819,986.59), Jonathan Rubin ($36,292.05), Padmanabh P Bhatt ($3,309,123.30), and Timothy C Dec ($524,092.20).

Insiders have sold a total of 669,649 Supernus Pharmaceuticals shares in the last 24 months for a total of $29,670,143.11 sold.

Gilbert Ray Cisneros, Jr. (D-CA) has bought shares of Supernus Pharmaceuticals in the last year totaling $16,000. Gilbert Ray Cisneros, Jr. (D-CA) has sold shares totaling $8,000.



This page (NASDAQ:SUPN) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners